| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.77B | 20.78B | 19.49B | 18.51B | 17.76B | 17.71B |
| Gross Profit | 9.71B | 9.09B | 7.85B | 6.99B | 5.88B | 5.44B |
| EBITDA | 6.29B | 5.51B | 4.58B | 3.95B | 3.14B | 2.62B |
| Net Income | 3.90B | 3.33B | 2.63B | 2.33B | 1.64B | 1.29B |
Balance Sheet | ||||||
| Total Assets | 19.38B | 18.48B | 15.72B | 13.41B | 11.50B | 10.51B |
| Cash, Cash Equivalents and Short-Term Investments | 9.93B | 9.35B | 8.38B | 6.97B | 4.95B | 4.08B |
| Total Debt | 0.00 | 100.00M | 100.00M | 100.00M | 100.00M | 470.78M |
| Total Liabilities | 5.51B | 5.10B | 4.77B | 4.13B | 4.02B | 4.20B |
| Stockholders Equity | 13.87B | 13.38B | 10.95B | 9.29B | 7.48B | 6.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.42B | 2.57B | 2.57B | 1.56B | 1.78B |
| Operating Cash Flow | 0.00 | 3.52B | 3.55B | 3.28B | 2.29B | 2.54B |
| Investing Cash Flow | 0.00 | -1.48B | -1.13B | -696.63M | -713.17M | -817.10M |
| Financing Cash Flow | 0.00 | -1.07B | -1.00B | -549.06M | -701.76M | 196.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥71.98B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
74 Outperform | ¥95.21B | 11.45 | ― | 2.59% | 5.22% | -6.62% | |
73 Outperform | ¥86.69B | 22.31 | ― | 1.19% | 22.78% | 7.57% | |
70 Outperform | ¥90.70B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
68 Neutral | ¥31.92B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥116.90B | 293.64 | ― | ― | 31.57% | ― |